Administration and effects of secondary prevention measures in coronary heart disease patients from Serbia according to gender and cardiometabolic risk

References

• Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747–57.
   Google Scholar
• Leal J, Luengo-Fernandez R, Gray A, Petersen S, Rayner M. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J 2006; 27: 1610–9.
   Google Scholar
• Pyör5.15. K, De Backer G, Graham I, Poole-Wilson P, WoodD. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J 1994; 15: 1300–31.
   Google Scholar
• Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyöräld K. Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis 1998; 140: 199–270.
   Google Scholar
• De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Cats VM, Orth-Gomér K, Perk J, Pyör5.15. K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D. European Society of Cardiology Committee for Practice Guidelines. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardio-vascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prey Rehabil 2003; 10: Si-S10.
   Google Scholar
• Graham I, Atar D, Borch-Johnsen K, Boysen G, Buren G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, RuilopeL, Sans-Menendez S, Op Reimer WS, Weissberg P, WoodD, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, DeanV, Dickstein K, Funck-Brentano C, Filippatos G, HellemansI, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Altiner A, BonoraE, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen L, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgözoglu L, Wiklund O, Zampelas A; European Society of Cardiology (ESC); European Association for Cardiovascular Prevention and Rehabilitation (EACPR); Council on Cardiovascular Nursing; European Association for Study of Diabetes (EASD); International Diabetes Federation EuropDF-Europe); European Stroke Initiative (EUSI); Society of Behavioural Medicine (ISBM); European Society of Hyper-tension (ESH); WONCA Europe (European Society of General Practice/Family Medicine); European Heart Net-work (EHN); European Atherosclerosis Society (EAS). European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prey Rehabil 2007; 14 (Suppl 2): S1–113.
   Google Scholar
• Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Ten-dera M, Widimsky P, Zamorano JL, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen ML, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sam-mut M, Schneiderman N, Stalenhoef AF, Tokgözoglu L, Wiklund O, Zampelas A; European Society of Cardiology (ESC); European Association for Cardiovascular Prevention and Rehabilitation (EACPR); Council on Cardiovascular Nursing; European Association for Study of Diabetes (EASD); International Diabetes Federation Epe (IDF-Europe); European Stroke Initiative (EUSI); International Society of Behavioural Medicine (ISBM); European Soci-ety of Hypertension (ESH); European Society of General Practice/Family Medicine (ESGP/FM/WONCA); European Heart Network (EHN). European guidelines on cardiovas-cular disease prevention in clinical practice: executive sum-mary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease pre-vention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prey Rehabil 2007; 14 (Suppl 2): E1-40.
   Google Scholar
• Balady GJ, Ades PA, Comoss P, Limacher M, Pina IL, Southard D, Williams MA, Bazzarre T. Core components of cardiac rehabilitation/secondary prevention programs: a statement for healthcare professionals from the American Heart Association and the American Association of Cardio-vascular and Pulmonary Rehabilitation Writing Group. Circulation 2000; 102: 1069–73.
   Google Scholar
• Kotseva K, Wood D, De Backer G, De Bacquer D, Pyör5.15. K, Keil U; EUROASPIRE Study Group. For the EURO-ASPIRE Study Group. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 2009; 373: 929–40.
   Google Scholar
• De Velasco JA, Cosin J, Lopez Sendón JL, de Teresa E, de Oya M, Carrasco JL, Navarro A. Secondary prevention of myocardial infarction in Spain. The PREVESE study. Rev Esp Cardiol 1997; 50: 406–15.
   Google Scholar
• De Velasco JA, Co sin J, Lemez-Sendón JL, De Teresa E, De Oya M, Sellers G. New data on secondary prevention of myocardial infarction in Spain. Results of the PREVESE II study. Rev Esp Cardiol 2002; 55: 801–9.
   Google Scholar
• Danchin N, Hanania G, Grenier O, Vaur L, Amelineau E, Guéret P, Blanchard D, Ferrières J, Genes N, Lablanche JM, Cantet C, Cambou JP. Trends in discharge prescriptions for patients hospitalized for acute coronary syndromes in France from 1995 to 2000. Data from the Usik 1995, Prevenir 1, Prevenir 2 and Usic 2000 surveys. Ann Cardiol Angeiol (Paris) 2003; 52: 1–6 [article in French].
   Google Scholar
• Reiner Z, Mihatov S, Milicié, Bergovec M, Planinc D. TASPIC-CRO Study Group Investigators. Treatment and sec-ondary prevention of ischemic coronary events in Croatia(TASPIC-CRO study). Eur J Cardiovasc Prey Rehab 2006; 13: 646–54.
   Google Scholar
• The Expert Panel. The Third Report of the National Edu-cation Program (NCEP) Expert Panel on Detection, Evalu-ation, and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel III). Final report. Circulation 2002; 106: 3143–421.
   Google Scholar
• World Health Organization: Definition, diagnosis and clas-sification of diabetes mellitus and its complications: report of a WHO Consultation. Part 1: diagnosis and classifica-tion of diabetes mellitus. Geneva: World Health Organiza-tion, 1999.
   Google Scholar
• Tonkin A. The metabolic syndrome — a growing problem. Eur Heart J 2004; 6 (Suppl A): A37-A42.
   Google Scholar
• Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709–16.
   Google Scholar
• Executive summary of the third report of the National cholesterol education program (NCEP). Expert panel on detection, evaluation, and treatment of high blood choles-terol in adults (Adult Treatment panel III). JAMA 2001; 285: 2486–97.
   Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol inplasma without use of preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.
   Google Scholar
• Giannuzzi P, Saner H, Björnstad H, Fioretti P, Mendes M, Cohen-Solal A, Dugmore L, Hambrecht R, Hellemans I, McGee H, Perk J, Vanhees L, Veress G. Working Group on Cardiac Rehabilitation and Exercise Physiology of the Euro-pean Society of Cardiology. Secondary prevention through cardiac rehabilitation: position paper of the Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology. Eur Heart J2003; 24: 273-8.
   Google Scholar
• Wood DA, Kotseva K, Connolly S, Jennings C, Mead A, Jones J, Holden A, De Bacquer D, Collier T, De Backer G, Faergeman O. EUROACTION Study Group. Nurse-coor-dinated multidisciplinary, family-based cardiovascular dis-ease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired cluster ran-domised controlled trial. Lancet 2008; 371: 1999–2012.
   Google Scholar
• Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 1994; 308: 367–2.
   Google Scholar
• Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 2003; 326: 1423–9.
   Google Scholar